Maninder Kapoor Puri joins as CHRO and Abhijit Zutshi as CCO
India/U.S./UK, 4 May 2026 :
Syngene International, a global contract research, development, and
manufacturing organization (CRDMO), today announced the appointment of Maninder
Kapoor Puri as Chief Human Resources Officer (CHRO) and Abhijit Zutshi as Chief
Commercial Officer (CCO), effective 1 May 2026.
Maninder Kapoor Puri is
a global HR leader with nearly three decades of experience driving business
performance through people, leadership, culture, and digital HR ecosystems.
Her experience spans biopharmaceuticals, IT
services, and consulting across North America, EMEA, and APAC. She has
partnered with CEOs and Boards to lead large-scale, multi-market
transformations, building high-performance organizations aligned to business
growth.
Most recently, as CHRO at Biocon, she led
enterprise-wide culture and leadership transformation. Prior to that, as Global
CHRO at Mastek, she led HR across 40+ countries and has held leadership roles
at Accenture and Firstsource Solutions. Maninder has been featured by Outlook
Business as a face of “Viksit Bharat” and recognized among HR Today’s Top 100
Global CHROs, India’s Most Agile Leaders (2026), and as a CHRO of the Year.
As Chief Human Resources Officer and a member
of the Executive Committee at Syngene, Maninder will be leading the company’s
global people agenda to support its next phase of growth.
Abhijit (Abhi) Zutshi
joins Syngene as Chief Commercial Officer and will be based in the United
States. As a member of the Executive Committee, Abhi will lead Syngene’s
commercial activities, including sales, client partnerships, marketing, brand
building, digital initiatives, and account management.
Abhi is a seasoned pharmaceutical executive
with nearly 27 years of commercial experience across global markets. He spent
25 years at Biocon, most recently as Chief Commercial Officer of the generics
business, where he led both the drug substance and drug product divisions and
built a global team focused on generic formulations. His career expertise spans
sales, marketing, business development, portfolio management, and market entry
strategy across small and large molecules. Earlier in his career, he held a
product specialist role at Pfizer, where he led the India launch of the Zosyn
brand. Abhi holds a degree in pharmacy, an MBA, and is a graduate of the Leadership
Development Program at Harvard Business School.
Commenting on the appointments, Peter
Bains, Managing Director and CEO, Syngene International, said, “We are
pleased to welcome Maninder and Abhijit to Syngene’s leadership team. Their
depth of experience and strong track record in their respective domains will be
instrumental as we continue to evolve our service offerings and enhance our
value proposition for clients worldwide. These appointments reinforce our
commitment to building a world-class leadership team capable of driving our
next phase of sustainable growth.”
About
Syngene: Syngene International Ltd. (BSE: 539268, NSE:
SYNGENE, ISIN: INE 398R01022) is an integrated research, development, and
manufacturing services company serving the global pharmaceutical,
biotechnology, nutrition, animal health, consumer goods, and specialty chemical
sectors. Syngene’s team of over 8,300 employees including 5,700+ scientists,
brings both deep expertise and the capacity to deliver scientific excellence,
robust data security, and world class manufacturing, at speed, to improve
time-to market and lower the cost of innovation. With over 3 Mn sq. ft of
specialized discovery, development, and manufacturing facilities across India
and the U.S., Syngene works with ~400 global customers across industry
segments, including biotech companies pursuing leading-edge science and
multinationals such as BMS, GSK, Zoetis, and Merck KGaA. For more details,
visit www.syngeneintl.com.
For the Company’s latest Environmental, Social, and Governance (ESG) report,
visit Syngene ESG Report.